Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
出版年份 2016 全文链接
标题
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
作者
关键词
-
出版物
HEPATOLOGY
Volume 65, Issue 1, Pages 350-362
出版商
Wiley
发表日期
2016-06-30
DOI
10.1002/hep.28709
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Nonalcoholic Fatty Liver Disease and the Gut Microbiome
- (2016) Jerome Boursier et al. Clinics in Liver Disease
- Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
- (2016) R. Pencek et al. DIABETES OBESITY & METABOLISM
- Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
- (2016) R. J. Hodge et al. DIABETES OBESITY & METABOLISM
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis
- (2016) Divya P. Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
- (2016) Giovanni Musso et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules
- (2016) Bryan L. Copple et al. PHARMACOLOGICAL RESEARCH
- Why high ‘good cholesterol’ can be bad news
- (2016) Jennifer Couzin-Frankel SCIENCE
- Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
- (2016) Claudia Fuchs et al. SEMINARS IN LIVER DISEASE
- Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health
- (2016) Susan A. Joyce et al. Annual Review of Food Science and Technology
- Insights on FXR selective modulation. Speculation on bile acid chemical space in the discovery of potent and selective agonists
- (2016) Valentina Sepe et al. Scientific Reports
- The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity
- (2015) Evie P.M. Broeders et al. Cell Metabolism
- FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
- (2015) Rotonya M. Carr et al. Current Atherosclerosis Reports
- Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
- (2015) Daniel Jahn et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
- (2015) Rohit Kohli et al. DIGESTIVE DISEASES
- Bariatric surgery and nonalcoholic fatty liver disease
- (2015) Guy Bower et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
- (2015) Niels van Best et al. Hepatology International
- The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease
- (2015) Kazuya Okushin et al. JOURNAL OF GASTROENTEROLOGY
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander
- (2015) Ester Vanni et al. SEMINARS IN LIVER DISEASE
- The Gut Microbiota and Nonalcoholic Fatty Liver Disease
- (2015) Howard Monsour et al. SEMINARS IN LIVER DISEASE
- Pharmacotherapy for Nonalcoholic Fatty Liver Disease
- (2015) Samer Gawrieh et al. SEMINARS IN LIVER DISEASE
- Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
- (2015) Sanjaya Satapathy et al. SEMINARS IN LIVER DISEASE
- TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
- (2015) Alessia Perino et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Genetic background in nonalcoholic fatty liver disease: A comprehensive review
- (2015) Fabio Salvatore Macaluso WORLD JOURNAL OF GASTROENTEROLOGY
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
- (2015) Lihua Jin et al. Scientific Reports
- Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
- (2015) Jorge C. Correia et al. Molecular Metabolism
- The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
- (2015) Jason M. Ridlon et al. Acta Pharmaceutica Sinica B
- Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids
- (2015) Courtney B. Ferrebee et al. Acta Pharmaceutica Sinica B
- Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction
- (2014) Xijun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- Nuclear bile acid signaling through the farnesoid X receptor
- (2014) Claire Mazuy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- State of the art
- (2014) Michelle Pearlman et al. CURRENT OPINION IN GASTROENTEROLOGY
- Bile acids and the gut microbiome
- (2014) Jason M. Ridlon et al. CURRENT OPINION IN GASTROENTEROLOGY
- Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
- (2014) Christian Gege et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The bile acid TGR5 membrane receptor: From basic research to clinical application
- (2014) Henri Duboc et al. DIGESTIVE AND LIVER DISEASE
- Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development
- (2014) Iker Uriarte et al. INTERNATIONAL JOURNAL OF CANCER
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal transport and metabolism of bile acids
- (2014) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- Bile acid receptors in non-alcoholic fatty liver disease
- (2013) Yuanyuan Li et al. BIOCHEMICAL PHARMACOLOGY
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
- (2013) Rachel H. McMahan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- Patented TGR5 modulators: a review (2006 – present)
- (2012) Antimo Gioiello et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
- (2012) Thuy-Anh Le et al. HEPATOLOGY
- Selection of the appropriate method for the assessment of insulin resistance
- (2011) Anwar Borai et al. BMC Medical Research Methodology
- Bile acid sequestrants
- (2011) Carolien Out et al. CURRENT OPINION IN LIPIDOLOGY
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
- (2011) J. Prawitt et al. DIABETES
- Hepatic Overexpression of Abcb11 Promotes Hypercholesterolemia and Obesity in Mice
- (2011) Anne S. Henkel et al. GASTROENTEROLOGY
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
- (2011) Bertrand Cariou et al. Nutrition & Metabolism
- Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte
- (2010) Fan Chao et al. ATHEROSCLEROSIS
- A common polymorphism in theABCB11gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease
- (2010) Rika Iwata et al. CLINICAL SCIENCE
- Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis
- (2010) N. Beraza et al. GUT
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
- (2010) Thijs W.H. Pols et al. JOURNAL OF HEPATOLOGY
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
- (2009) Peter Fickert et al. AMERICAN JOURNAL OF PATHOLOGY
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
- (2009) Roberto Pellicciari et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search